跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺科飞 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Posaconazole Oral Suspension
Approved
化学药品
Posaconazole Oral Suspension
Merck Sharp & Dohme BV
🇨🇳 National Medical Products Administration
Approval Date
Nov 18, 2022
Approval ID
e0cfbee99aecd370
Company
Merck Sharp & Dohme BV
Type
化学药品
Approval Details
Approval Id
e0cfbee99aecd370
Approval Number
国药准字HJ20181110
Generic Name
泊沙康唑口服混悬液
Generic Name En
Posaconazole Oral Suspension
Trade Name
诺科飞
Drug Type
化学药品
Dosage Form
口服混悬剂
Strength
40mg/ml
Reg Date
2022-11-18
Expired Date
2027-11-17
Company Name
Merck Sharp & Dohme BV
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 18, 2022
Approval ID
e0cfbee99aecd370
Type
化学药品
Back to NMPA Approvals